Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Promising combo aims to stop triple negative breast cancer from coming back

NCT ID NCT05949021

First seen Nov 16, 2025 · Last updated May 23, 2026 · Updated 20 times

Summary

This study tests whether a combination of two chemotherapy drugs, liposomal doxorubicin and carboplatin, given after surgery can lower the chance of cancer returning in people with early-stage triple negative breast cancer. About 30 participants will receive the treatment and be monitored for side effects and cancer recurrence. The study also looks at a blood test for tumor DNA to help predict treatment response.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TRIPLE NEGATIVE BREAST CANCER (TNBC) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • RWJBarnabas Health - Community Medical Center

    Toms River, New Jersey, 08755, United States

  • RWJBarnabas Health - Monmouth Medical Center Southern Campus

    Lakewood, New Jersey, 08701, United States

  • RWJBarnabas Health - Newark Beth Israel Medical Center

    Newark, New Jersey, 07112, United States

  • RWJBarnabas Health - Robert Wood Johnson University Hospital

    New Brunswick, New Jersey, 08903, United States

  • RWJBarnabas Health - Trinitas hospital and Comprehensive Center

    Elizabeth, New Jersey, 08755, United States

  • RWJBarnabas Health Jersey City Medical Center

    Jersey City, New Jersey, 07302, United States

  • Rutgers Cancer Institute of New Jersey

    New Brunswick, New Jersey, 08903, United States

  • University Hospital-Newark

    Newark, New Jersey, 07112, United States

Conditions

Explore the condition pages connected to this study.